MLL/KMT2A Antikörper (AA 161-356)
Kurzübersicht für MLL/KMT2A Antikörper (AA 161-356) (ABIN2668648)
Target
Alle MLL/KMT2A (MLL) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 161-356
-
Aufreinigung
- Protein G Chromatography
-
Immunogen
- This MLL1 antibody was raised against a recombinant protein corresponding to amino acids 161-356 of mouse MLL1.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1 μg/μL
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
-
Avoid repeated freeze/thaw cycles and keep on ice when not in storage.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Antibodies in solution can be stored at -20 °C for 2 years.
-
Haltbarkeit
- 6 months
-
-
-
NAD(+)-SIRT1 control of H3K4 trimethylation through circadian deacetylation of MLL1." in: Nature structural & molecular biology, Vol. 22, Issue 4, pp. 312-8, (2015) (PubMed).
: "c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis." in: The Journal of clinical investigation, Vol. 120, Issue 2, pp. 593-606, (2010) (PubMed).
: "
-
NAD(+)-SIRT1 control of H3K4 trimethylation through circadian deacetylation of MLL1." in: Nature structural & molecular biology, Vol. 22, Issue 4, pp. 312-8, (2015) (PubMed).
-
- MLL/KMT2A (MLL) (Myeloid/lymphoid Or Mixed-Lineage Leukemia (MLL))
-
Andere Bezeichnung
- MLL / HRX
-
Molekulargewicht
- 440 kDa
-
Gen-ID
- 4297
-
Pathways
- Warburg Effekt
Target
-